Skip to content

Pylorus resection versus pylorus preservation in pancreatoduodenectomy: A multicenter surgical registry-based randomized active-controlled trial (RRCT) from the German DGAV StuDoQ|Pancreas Registry

Pylorus resection versus pylorus preservation in pancreatoduodenectomy: A multicenter surgical registry-based randomized active-controlled trial (RRCT) from the German DGAV StuDoQ|Pancreas Registry - PyloResPres-TRIAL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00018842
Enrollment
982
Registered
2019-10-24
Start date
2019-11-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K31.9 T81.9

Interventions

Group 1: pylorus preserving group (ppPP) Group 2: pylorus resecting group (prPD)

Sponsors

LMU Klinikum München Anstalt des öffentlichen Rechts
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients in which a partial pancreatoduodenectomy (PD) needs to be performed Any patient aged 18 years or older scheduled for PD for any indication with written informed consent is eligible

Exclusion criteria

Exclusion criteria: -Patients who participate in another intervention trial interfering with the surgical intervention or the outcome of this Trial -Patients with expected lack of compliance and/or irreconcilable language barriers will be excluded -Classic Whipple operation

Design outcomes

Primary

MeasureTime frame
Primary efficacy endpoint is the frequency of postoperative DGE (delayed gastric emptying) according to the international ISGPS definition 30 days after index operation, compared between the two intervention groups

Secondary

MeasureTime frame
severe morbidity (Clavien Dindo classification<3b vs =3b), blood loss (ml), 30 day mortality (death from any cause), postoperative hospital stay, insufficiency of the gastro/pylorojejunostomy, operation time, initiation of adjuvant chemotherapy in cancer patients

Countries

Germany

Contacts

Public ContactBernhard Renz

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie Klinikum der Universität München Campus Großhadern

Bernhard.Renz@med.uni-muenchen.de089/4400711205

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 14, 2026